Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Drugs & Aging|February 1, 2011
Inactivated influenza vaccines: recent progress and implications for the elderlyValentina Parodi, Daniela de Florentiis, Mariano Martini, et al.
Expert Review of Vaccines|December 14, 2011
Fluzone(®) Intradermal vaccine: a promising new chance to increase the acceptability of influenza vaccination in adultsFilippo Ansaldi, Daniela de Florentiis, Paolo Durando, et al.
Clinical and Vaccine Immunology : CVI|December 24, 2010
Increasing incidence of Streptococcus pneumoniae serotype 19A and emergence of two vaccine escape recombinant ST695 strains in Liguria, Italy, 7 years after implementation of the 7-valent conjugated vaccineFilippo Ansaldi, Paola Canepa, Daniela de Florentiis, et al.
International Journal of Antimicrobial Agents|September 18, 2010
High-dose daptomycin in documented Staphylococcus aureus infectionsMatteo Bassetti, Elena Nicco, Francesca Ginocchio, et al.
Vaccine|February 7, 2012
Carriage of Streptoccoccus pneumoniae 7 years after implementation of vaccination program in a population with very high and long-lasting coverage, ItalyFilippo Ansaldi, Daniela de Florentiis, Paola Canepa, et al.
Human Vaccines & Immunotherapeutics|January 9, 2013
Head-to-head comparison of an intradermal and a virosome influenza vaccine in patients over the age of 60: evaluation of immunogenicity, cross-protection, safety and tolerabilityFilippo Ansaldi, Andrea Orsi, Daniela de Florentiis, et al.
Plos One|May 27, 2015
Clinical and therapeutic aspects of candidemia: a five year single centre studyMatteo Bassetti, Maria Merelli, Filippo Ansaldi, et al.
Human Vaccines & Immunotherapeutics|January 9, 2013
Cross-protection against drifted influenza viruses: options offered by adjuvanted and intradermal vaccinesAndrea Orsi, Filippo Ansaldi, Daniela de Florentiis, et al.
Human Vaccines & Immunotherapeutics|July 27, 2012
Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adultsFilippo Ansaldi, Laura Valle, Daniela de Florentiis, et al.
Vaccine|February 21, 2012
Intanza(®) 15 mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza virusesFilippo Ansaldi, Paola Canepa, Antonella Ceravolo, et al.
Pageof 2